» Articles » PMID: 2419762

Differential Expression of Myc Family Genes During Murine Development

Overview
Journal Nature
Specialty Science
Date 1986 Feb 5
PMID 2419762
Citations 191
Authors
Affiliations
Soon will be listed here.
Abstract

The myc family of cellular oncogenes contains three known members. The N-myc and c-myc genes have 5'-noncoding exons, strikingly homologous coding regions, and display similar oncogenic potential in an in vitro transformation assay. The L-myc gene is less well characterized, but shows homology to N-myc and c-myc (ref. 6; also see below). c-myc is expressed in most dividing cells, and deregulated expression of this gene has been implicated in the development of many classes of tumours. In contrast, expression of N-myc has been found only in a restricted set of tumours, most of which show neural characteristics; these include human neuroblastoma, retinoblastoma and small cell lung carcinoma (SCLC). L-myc expression has so far been found only in SCLC. Activated N-myc and L-myc expression has been implicated in oncogenesis; for example, although N-myc expression has been found in all neuroblastomas tested, activated (greatly increased) N-myc expression, resulting from gene amplification, is correlated with progression of the tumour. We now report that high-level expression of N- and L-myc is very restricted with respect to tissue and stage in the developing mouse, while that of c-myc is more generalized. Furthermore, we demonstrate that N-myc is not simply a neuroectoderm-specific gene; both N- and L-myc seem to be involved in the early stages of multiple differentiation pathways. Our findings suggest that differential myc gene expression has a role in mammalian development and that the normal expression patterns of these genes generally predict the types of tumours in which they are expressed or activated.

Citing Articles

MYC in cancer: from undruggable target to clinical trials.

Whitfield J, Soucek L Nat Rev Drug Discov. 2025; .

PMID: 39972241 DOI: 10.1038/s41573-025-01143-2.


A phenome-wide association study of polygenic scores for selected childhood cancer: Results from the UK Biobank.

Jung E, Raduski A, Mills L, Spector L HGG Adv. 2024; 6(1):100356.

PMID: 39340156 PMC: 11538869. DOI: 10.1016/j.xhgg.2024.100356.


Expansion of a neural crest gene signature following ectopic MYCN expression in sympathoadrenal lineage cells in vivo.

Ibarra-Garcia-Padilla R, Nambiar A, Hamre T, Singleton E, Uribe R PLoS One. 2024; 19(9):e0310727.

PMID: 39292691 PMC: 11410271. DOI: 10.1371/journal.pone.0310727.


Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation.

Acosta-Plasencia M, Castellano J, Diaz T, He Y, Marrades R, Navarro A Stem Cell Res Ther. 2024; 15(1):263.

PMID: 39183355 PMC: 11346212. DOI: 10.1186/s13287-024-03883-1.


Immune evasion: An imperative and consequence of MYC deregulation.

Krenz B, Lee J, Kannan T, Eilers M Mol Oncol. 2024; 18(10):2338-2355.

PMID: 38957016 PMC: 11459038. DOI: 10.1002/1878-0261.13695.